Company profile

Asensus Surgical

Surgical AI & Robotics

Company profile

About Asensus Surgical

Asensus Surgical is revolutionizing minimally invasive surgery through the integration of advanced robotics and Augmented Intelligence. The company's flagship Senhance® Surgical System features an open ergonomic design with haptic feedback and eye-tracking camera control, combined with reusable 3mm and 5mm instruments. The Intelligent Surgical Unit™ (ISU™) represents the first intraoperative Augmented Intelligence system approved for use globally, providing surgeons with real-time data-driven insights during procedures. Asensus's digital solutions include AI Sight for eye-tracking camera control, AI Precision for intraoperative 3D measurement, and AI Annotation for enhanced surgical team communication. The augmentOR™ Portal provides cloud-based access to surgical data, video libraries, performance analytics, and trend analysis to support continuous learning and workflow optimization. Part of KARL STORZ, Asensus serves surgeons, hospital administrators, and healthcare systems worldwide across multiple surgical specialties including general surgery, gynecology, urology, and pediatrics. The company's mission is to make safer, more predictable surgical procedures accessible by combining groundbreaking robotic technology with actionable intelligence that enhances surgeon decision-making without replacing human expertise.

Company description Asensus Surgical official website

Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Asensus Surgical?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • General surgery
  • Gynecology
  • Hernia repair
  • Oncology
  • Pediatric surgery
  • Prostatectomy
  • Urology

Who it serves

  • Health Systems
  • Hospital Administrators
  • Hospitals
  • Surgeons

Deployment & integration

Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.

Geographic context

MarketsGlobal · International markets mentioned with physician partners worldwide
Company sourceOfficial website

Company milestones

Platform expansion

Multiple 2025 awards including Best in Biz Tech for Good, Merit Awards Health Tech Innovation, eHealthcare Leadership Award, MarCom Awards, Globee Business Awards Most Innovative Healthcare Company, NC Tech Awards Finalist, Digital Health Award, Surgical Robotics Industry Awards Finalist, TITAN Health Awards

Partnerships

Recorded partners

  • KARL STORZ (parent company/acquirer)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

AI Annotation

Digital tagging system for enhanced OR communication and coordination

Software · EmbeddedCompany source

AI Precision

Intraoperative 3D measurement tool for enhanced procedural reproducibility

Software · EmbeddedCompany source

AI Sight

Eye-tracking and instrument-guided camera control for autonomous surgical visualization

Software · EmbeddedCompany source

augmentOR™ Portal

Cloud-based surgical analytics platform for performance insights and continuous learning

Platform · Cloud SaaSCompany source

Intelligent Surgical Unit™ (ISU™)

Real-time Augmented Intelligence system providing intraoperative surgical insights

Software · EmbeddedCompany source

Senhance® Connect

Connectivity solution for the Senhance Surgical System

Software · HybridCompany source

Senhance® Simulation

Training and simulation platform for Senhance robotic surgery

Software · On PremiseCompany source

Senhance® Surgical System

Advanced robotic-assisted surgical system with open ergonomic design and reusable instruments

Device · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Enhanced surgeon decision-making

Real-time insights during surgery

Improved surgical efficiency and quality

Through Augmented Intelligence features

Optimized OR collaboration

Among surgical team members

Procedural reproducibility

Through AI Precision measurement tools

Multi-center study (3,239 patients)

Safety evaluation of Senhance robotic system across various surgical disciplines

Demonstrated safety across 3,239 patients in multiple surgical disciplines

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Dustin Vaughan

Dustin Vaughan

Vice President, R&D, Robotics

LinkedIn

06 · Company updates

Updates from Asensus Surgical

Recent articles published on Asensus Surgical's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Surgical AI & Robotics

Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon